SAN DIEGO, Oct. 28, 2013 (GLOBE NEWSWIRE) -- MyEZSmokes Inc. (OTC:XRMB) has recently unveiled a new web portal presence (www.myezsmokes.com) that supports the company's direct distribution sales model concept. Through this network marketing model, the company will generate new partnerships with interested candidates who can become MyEZSmokes Independent Sales Representatives. These partners or 'team members' will find the program easy to participate in and simple to understand; and will receive the support, tools and skills training needed to be successful.
Mr. Balsiger stated, "We are very excited about the rollout of our new web portal. It is designed to offer both interested consumers and potential retail partner's distribution and purchasing options. It offers a unique distribution partner network opportunity that offers a substantial profit proposition we believe will significantly drive the sales of our products over the next several years through a network marketing presence. Our general goal of becoming one of the top ten in this product channel should allow us to achieve a healthy profit while providing a good return to our shareholders."
Mr. Balsiger further stated, "Our focus is on building a company that is based on positive relationships and integrity. We believe that it is our responsibility to share our opportunity with everyone and provide an equal setting in which anyone can prosper."
About MyEZsmokes Inc. (www.myezsmokes.com)
Headquartered in San Diego, California, MyEZsmokes Inc. engages in the manufacture and distribution of electronic cigarettes. The company offers disposable and starter kits e-cigarettes as well as cartomizers in tobacco and menthol flavors branded under the ICON Vapor Products line. For further information please contact the Company at:
(858.509.2783 or Sales@myezsmokes.com)
Safe Harbor Statement
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTCBB website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements. Additionally, our 1-A registration statement will generate additional free trading shares to the marketplace at a pre-determined price which may impact our share pricing within the OTC marketplace in a manner that we cannot predict.